Aclaris Therapeutics Joins Nasdaq Biotechnology Index
I'm PortAI, I can summarize articles.
Aclaris Therapeutics Inc. will be added to the Nasdaq Biotechnology Index (NBI) on December 19, 2025, following the annual evaluation of the index. This inclusion requires companies to meet specific criteria, such as minimum market capitalization and average daily trading volume. The original content was published by Aclaris Therapeutics Inc. via GlobeNewswire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments